Paul Daniel to Treatment Outcome
This is a "connection" page, showing publications Paul Daniel has written about Treatment Outcome.
Connection Strength
0.010
-
Heier JS, Brown D, Ciulla T, Abraham P, Bankert JM, Chong S, Daniel PE, Kim IK. Ranibizumab for choroidal neovascularization secondary to causes other than age-related macular degeneration: a phase I clinical trial. Ophthalmology. 2011 Jan; 118(1):111-8.
Score: 0.010